Filing Details

Accession Number:
0001127602-11-026789
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-10-04 17:57:06
Reporting Period:
2011-10-03
Filing Date:
2011-10-04
Accepted Time:
2011-10-04 16:57:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520262 Alkermes Plc. ALKS Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1126490 F Richard Pops Treasury Building
Lower Grand Canal Street
Dublin 2 Ireland
Director And Ceo, Alkermes Plc Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-10-03 89,418 $14.25 334,936 No 4 S Direct
Common Stock Disposition 2011-10-03 10,582 $15.07 324,354 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.91 to $14.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.91 to $15.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.